Myocardial scar and mortality in severe aortic stenosis: data from the BSCMR valve consortium
Background: Aortic valve replacement (AVR) for aortic stenosis is timed primarily on the
development of symptoms, but late surgery can result in irreversible myocardial dysfunction …
development of symptoms, but late surgery can result in irreversible myocardial dysfunction …
[HTML][HTML] Left ventricular blood flow kinetic energy after myocardial infarction-insights from 4D flow cardiovascular magnetic resonance
P Garg, S Crandon, PP Swoboda, GJ Fent… - Journal of …, 2018 - Elsevier
Background Myocardial infarction (MI) leads to complex changes in left ventricular (LV)
haemodynamics that are linked to clinical outcomes. We hypothesize that LV blood flow …
haemodynamics that are linked to clinical outcomes. We hypothesize that LV blood flow …
[HTML][HTML] Assessment of stable coronary artery disease by cardiovascular magnetic resonance imaging: Current and emerging techniques
JRJ Foley, S Plein, JP Greenwood - World Journal of Cardiology, 2017 - ncbi.nlm.nih.gov
Coronary artery disease (CAD) is a leading cause of death and disability worldwide.
Cardiovascular magnetic resonance (CMR) is established in clinical practice guidelines with …
Cardiovascular magnetic resonance (CMR) is established in clinical practice guidelines with …
Left ventricular thrombus formation in myocardial infarction is associated with altered left ventricular blood flow energetics
Aims The main aim of this study was to characterize changes in the left ventricular (LV)
blood flow kinetic energy (KE) using four-dimensional (4D) flow cardiovascular magnetic …
blood flow kinetic energy (KE) using four-dimensional (4D) flow cardiovascular magnetic …
Comparison of fast acquisition strategies in whole‐heart four‐dimensional flow cardiac MR: Two‐center, 1.5 Tesla, phantom and in vivo validation study
P Garg, JJM Westenberg… - Journal of Magnetic …, 2018 - Wiley Online Library
Purpose To validate three widely‐used acceleration methods in four‐dimensional (4D) flow
cardiac MR; segmented 4D‐spoiled‐gradient‐echo (4D‐SPGR), 4D‐echo‐planar‐imaging …
cardiac MR; segmented 4D‐spoiled‐gradient‐echo (4D‐SPGR), 4D‐echo‐planar‐imaging …
[HTML][HTML] Fully automated, inline quantification of myocardial blood flow with cardiovascular magnetic resonance: repeatability of measurements in healthy subjects
Background Non-invasive assessment of myocardial ischaemia is a cornerstone of the
diagnosis of coronary artery disease. Measurement of myocardial blood flow (MBF) using …
diagnosis of coronary artery disease. Measurement of myocardial blood flow (MBF) using …
[HTML][HTML] Impact of age and diastolic function on novel, 4D flow CMR biomarkers of left ventricular blood flow kinetic energy
S Crandon, JJM Westenberg, PP Swoboda, GJ Fent… - Scientific reports, 2018 - nature.com
Abstract Two-dimensional (2D) methods of assessing mitral inflow velocities are pre-load
dependent, limiting their reliability for evaluating diastolic function. Left ventricular (LV) blood …
dependent, limiting their reliability for evaluating diastolic function. Left ventricular (LV) blood …
Acute infarct extracellular volume mapping to quantify myocardial area at risk and chronic infarct size on cardiovascular magnetic resonance imaging
Background—Late gadolinium enhancement (LGE) imaging overestimates acute infarct
size. The main aim of this study was to investigate whether acute extracellular volume (ECV) …
size. The main aim of this study was to investigate whether acute extracellular volume (ECV) …
[HTML][HTML] Extra-cellular expansion in the normal, non-infarcted myocardium is associated with worsening of regional myocardial function after acute myocardial …
Background Expansion of the myocardial extracellular volume (ECV) is a surrogate measure
of focal/diffuse fibrosis and is an independent marker of prognosis in chronic heart disease …
of focal/diffuse fibrosis and is an independent marker of prognosis in chronic heart disease …
Myocardial effects of aldosterone antagonism in heart failure with preserved ejection fraction
AK McDiarmid, PP Swoboda, B Erhayiem… - Journal of the …, 2020 - Am Heart Assoc
Background Spironolactone may have prognostic benefit in selected patients with heart
failure with preserved ejection fraction. This study assessed the myocardial tissue effects of …
failure with preserved ejection fraction. This study assessed the myocardial tissue effects of …